From the Journals

Discovery of Novel Susceptibility Gene May Shed Light on Etiology of Psoriatic Arthritis Mutilans

Researchers may have uncovered genetic mechanisms underlying psoriatic arthritis mutilans.

Share

4 Key Takeaways

  • 1

    Study published in EMBO Mol Med uncovers genetic mechanisms related to psoriatic arthritis mutilans.

  • 2

    Rare variants in NOX4 gene potentially increase reactive oxygen species (ROS) levels.

  • 3

    NOX4's role in osteoclast differentiation implicated.

  • 4

    Findings could lead to new therapeutic interventions.

Original Source(s)

Discovery of Novel Susceptibility Gene May Shed Light on Etiology of Psoriatic Arthritis Mutilans

Researchers may have uncovered genetic mechanisms underlying psoriatic arthritis mutilans.

  • by Conexiant News Staff

  • April 30, 2024

  • 2 min

Related Content

‘Patent Dance’ Delays Biosimilars Despite FDA Shift

The FDA moves to speed biosimilar approvals, but rising patent barriers may still delay lower-cost alternatives.

FDA Pushes Faster, Cheaper Route for Biosimilar Approval

The FDA released new draft guidance to streamline biosimilar development.

PsA Clusters Identified for Tailored Treatment: Longitudinal Study